BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SHR-3079 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of SHR-3079\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07661537-11099@assetmemo.bio
DTSTAMP:20261121T004553Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:SHR-3079: Phase 1 readout est. (NCT07661537)
DESCRIPTION:SHR-3079\, phase 1\, B-Cell Non-Hodgkin Lymphoma.\nStudy: A Cli
 nical Study of SHR-3079 in B-cell Non-Hodgkin Lymphoma\nEstimated primary 
 completion: December 2027. This is a ClinicalTrials.gov estimate\, not a c
 onfirmed readout date\, and it can move.\nDrug page: https://assetmemo.bio
 /drug/shr-3079#upcoming-events\nRegistry record: https://clinicaltrials.go
 v/study/NCT07661537
URL:https://assetmemo.bio/drug/shr-3079#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
